.png)
BioPharma Unscripted!
BioPharma Unscripted! connects leaders across biotech, pharma and healthcare to share insights that bridge US and European markets. Hosted by Marcus Metcalfe, this podcast brings together emerging biotech leaders, market access specialists and industry innovators to explore the challenges and opportunities in bringing life-changing treatments to patients.
Each episode features thought-provoking conversations with industry experts who share their journeys, strategies and practical advice on navigating market access, health economics and the complex healthcare landscape. With a focus on both interim leadership solutions and permanent placements, Marcus brings his relationship-driven approach to deliver valuable insights for professionals at all stages of their career.
Whether you're part of an emerging biotech company, an established pharmaceutical organisation or somewhere in between, this podcast offers a wealth of knowledge on building teams, developing market strategies and driving healthcare innovation forward. Join Marcus as he bridges the gap between US and European markets, providing a platform where science meets business strategy and technical expertise meets human connection.
Subscribe now for weekly episodes featuring the brightest minds in biotech and pharmaceutical market access.
BioPharma Unscripted!
Building Successful Market Access Strategies from Day One - BioPharma Unscripted Ep. 6
Building Successful Market Access Strategies from Day One - BioPharma Unscripted Ep. 6
In this episode of BioPharma Unscripted!, host Marcus speaks with pharmaceutical market access expert Ana Filipa Alexandre, PharmD, MPH about the critical importance of early access planning in drug development.
Ana shares insights from her extensive career spanning regulatory affairs, health economics, and market access, explaining why companies must consider access strategies from the earliest stages of development.
In This Episode You'll Learn
- What market access truly encompasses beyond regulatory approval
- Why companies frequently fail to start market access planning early enough
- How to build a compelling "value story" with evidence-based value propositions
- The specific consequences when market access planning is inadequate
- Special considerations for small biotech companies with limited resources
- The critical relationship between health economics and market access functions
- Why post-launch market access activities remain important throughout a product's lifecycle
- How the upcoming Joint Clinical Assessment (JCA) might impact European market access
Whether you're a pharmaceutical professional, biotech entrepreneur or healthcare policy expert, this episode offers valuable insights into how successful drugs make the journey from lab to patient.
Ana Filipa Alexandre, PharmD, MPH: Ana is a pharmacist by training with extensive experience in market access across affiliate and global roles. Connect with Ana on LinkedIn: https://www.linkedin.com/in/ana-filipa-alexandre-pharmd-mph/
Chapters
00:00 Introduction and Ana's background
01:31 Ana's journey into pharmaceutical market access
02:25 Defining market access as a process
04:44 Why companies fail to start market access planning early
07:06 Cross-functional collaboration in market access
08:26 Building the value story for new products
11:04 Challenges for small biotech companies
13:24 Example of effective early access planning
16:38 Advice for early-stage biotechs on market access
19:40 The role of consultants vs in-house expertise
21:42 Consequences of inadequate market access planning
24:16 Career development in market access
27:11 Post-launch considerations in market access
29:19 Concluding remarks
Connect with Marcus and Elucid8: https://www.linkedin.com/in/marcus-metcalfe-8938a35/ Marcus helps US & European Biotech & Pharmaceutical clients by providing Interim/Fractional & Advisory consultants for operational & strategic needs.
I also work selective Executive Search (perm) projects.
I have helped Clients when there is no headcount, when they can't find the right permanent candidate, when they have a spike in business, as an alternative to an external vendor or for those simply needing an extra pair of hands.
If you need a partner with an extensive network in HEOR and Market Access - this is his sweet spot.
He has placed over 120 HEOR and Market Access candidates during my time across US and Europe.
With his business partners, he covers the below functional areas.
• Biometrics • Business Development
• Clinical Research • Drug safety & Product safety
• Engineering • Health Economics
• Medical Affairs • Market Access
• Regulatory Affairs • Compliance/Quality Assurance
• Marketing & Medical • Scientific & Preclinical
• Communications
Sponsor Message
This episode is brought to you by www.elucid8.co - Connecting Talent, Strategy, and Investment to Transform Life Sciences
Podcast produced by www.podforge.co.uk